The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Epidemiology of β-Lactamase-Producing Pathogens
Open accessAbstract
β-Lactam antibiotics have been widely used as therapeutic agents for the past 70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases. Although penicillinases in Staphylococcus aureus challenged the initial uses of penicillin, β-lactamases are most important in Gram-negative bacteria, particularly in enteric and nonfermentative pathogens, where collectively they confer resistance to all β-lactam-containing antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Self-citationYong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Self-citationA functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Self-citationUpdated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367 · cited 9×
“subgroups of class A, class C, and class D enzymes (39).”
BackgroundMethodInfluentialSelf-citationJacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Self-citationClinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Logan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,584
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494 · cited 1×
“The CTX-M-type enzymes can be phylogenetically divided into five distinct clusters in which the group members share 94% identity (in contrast, 90% identity is observed between the members belonging to the other groups) (154).”
BackgroundStenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Self-citationAn Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Tooke, C. L., Hinchliffe, P., Bragginton, E. C., Colenso, C. K., Hirvonen, V. H. A., Takebayashi, Y., & Spencer, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.002 · Cited by 1,016
The global epidemiology of carbapenemase-producing Enterobacteriaceae
van Duin, D., & Doi, Y. (2017) · Virulence · doi:10.1080/21505594.2016.1222343 · Cited by 1,004
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Acinetobacter baumannii: evolution of a global pathogen
Antunes, L. C. S., Visca, P., & Towner, K. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12125 · Cited by 925
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 895
Hartman, B. J., & Tomasz, A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.513-516.1984 · Cited by 890
Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Program, N. C. S., Henderson, D. K., Palmore, T. N., & Segre, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004129 · Cited by 863
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01019-15 · Cited by 852
Past and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Self-citationPlasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 816
Evans, B. A., & Amyes, S. G. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-13 · Cited by 815
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790 · cited 1×
“expanded into nursing homes and community settings as well (55, 166).”
BackgroundEpidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
David, S., Reuter, S., Harris, S. R., Glasner, C., Feltwell, T., Argimon, S., Abudahab, K., Goater, R., Giani, T., Errico, G., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0492-8 · Cited by 773
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings
Wu, W., Feng, Y., Tang, G., Qiao, F., McNally, A., & Zong, Z. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-18 · Cited by 700
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
Nordmann, P., & Poirel, L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12719 · Cited by 679
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Bacterial Resistance: Origins, Epidemiology, and Impact
Livermore, D. M. (2003) · Clinical Infectious Diseases · doi:10.1086/344654 · Cited by 586
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae
DATTA, N., & KONTOMICHALOU, P. (1965) · Nature · doi:10.1038/208239a0 · Cited by 569
Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J.-D., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.891-897.2000 · Cited by 562
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. B. (1988) · PubMed · Cited by 532
Interplay between β-lactamases and new β-lactamase inhibitors
Bush, K., & Bradford, P. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0159-8 · Cited by 531
Self-citationGenetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene
Naas, T., Cuzon, G., Villegas, M.-V., Lartigue, M.-F., Quinn, J. P., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-07 · Cited by 515
Rosenthal, V. D., Bijie, H., Maki, D. G., Mehta, Y., Apisarnthanarak, A., Medeiros, E. A., Leblebicioglu, H., Fisher, D., Álvarez-Moreno, C., Khader, I. A., et al. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.05.020 · Cited by 511
Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci
Kirby, W. M. M. (1944) · Science · doi:10.1126/science.99.2579.452 · Cited by 502
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Zarrilli, R., Pournaras, S., Giannouli, M., & Tsakris, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.008 · Cited by 496
Wiener, J. (1999) · JAMA · doi:10.1001/jama.281.6.517 · Cited by 485
Bradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Self-citationAntibiotic resistance in staphylococci
Livermore, D. M. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00299-5 · Cited by 471
Schwaber, M. J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., Shalit, I., Carmeli, Y., & the Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir025 · Cited by 453
Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.563 · Cited by 450
Self-citationPeirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443
Woodford, N., Tierno, P. M., Young, K., Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D., Silver, L. L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4793-4799.2004 · Cited by 442
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Resistance of Staphylococcus aureus to the Action of Penicillin.
Rammelkamp, C. H., & Maxon, T. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-51-13986 · Cited by 416
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins
Kliebe, C., Nies, B. A., Meyer, J. F., Tolxdorff-Neutzling, R. M., & Wiedemann, B. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.302 · Cited by 415
Quale, J., Bratu, S., Gupta, J., & Landman, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1633-1641.2006 · Cited by 409
Jaurin, B., & Grundström, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4897 · Cited by 390
Critical analysis of antibacterial agents in clinical development
Theuretzbacher, U., Bush, K., Harbarth, S., Paul, M., Rex, J. H., Tacconelli, E., & Thwaites, G. E. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0340-0 · Cited by 373
Self-citationKinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Durand-Réville, T. F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485979 · Cited by 372
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Lomovskaya, O., Sun, D., Rubio-Aparicio, D., Nelson, K., Tsivkovski, R., Griffith, D. C., & Dudley, M. N. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-17 · Cited by 353
Peirano, G., & Pitout, J. D. D. (2019) · Drugs · doi:10.1007/s40265-019-01180-3 · Cited by 328
β-Lactamases: A Focus on Current Challenges
Bonomo, R. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025239 · Cited by 318
The continuing challenge of ESBLs
PEREZ, F., ENDIMIANI, A., HUJER, K., & BONOMO, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.003 · Cited by 298
Lemos, E. V., de la Hoz, F. P., Einarson, T. R., McGhan, W. F., Quevedo, E., Castañeda, C., & Kawai, K. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12363 · Cited by 296
Trias, J., & Nikaido, H. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.52 · Cited by 291
Biosynthesis of the Peptidoglycan of Bacterial Cell Walls
Izaki, K., Matsuhashi, M., & Strominger, J. L. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93393-4 · Cited by 290
Carlson, C. J., Kracalik, I. T., Ross, N., Alexander, K. A., Hugh-Jones, M. E., Fegan, M., Elkin, B. T., Epp, T., Shury, T. K., Zhang, W., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0435-4 · Cited by 290
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Drawz, S. M., Papp-Wallace, K. M., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00826-13 · Cited by 286
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf240 · Cited by 284
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Walther-Rasmussen, J., & Høiby, N. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm226 · Cited by 271
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
Hong, D. J., Bae, I. K., Jang, I.-H., Jeong, S. H., Kang, H.-K., & Lee, K. (2015) · Infection & Chemotherapy · doi:10.3947/ic.2015.47.2.81 · Cited by 271
Berrazeg, M., Jeannot, K., Ntsogo Enguéné, V. Y., Broutin, I., Loeffert, S., Fournier, D., & Plésiat, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-15 · Cited by 268
A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131
Banerjee, R., & Johnson, J. R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02824-14 · Cited by 268
Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae
Spratt, B. G. (1988) · Nature · doi:10.1038/332173a0 · Cited by 253
Murray, B. E., & Mederski-Samaroj, B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111042 · Cited by 253
Satlin, M. J., Chen, L., Patel, G., Gomez-Simmonds, A., Weston, G., Kim, A. C., Seo, S. K., Rosenthal, M. E., Sperber, S. J., Jenkins, S. G., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02349-16 · Cited by 252
The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world
Doi, Y., Iovleva, A., & Bonomo, R. A. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/taw102 · Cited by 248
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Escherichia coli ST131: a multidrug-resistant clone primed for global domination
Pitout, J. D. D., & DeVinney, R. (2017) · F1000Research · doi:10.12688/f1000research.10609.1 · Cited by 240
Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
Eichenberger, E. M., & Thaden, J. T. (2019) · Antibiotics · doi:10.3390/antibiotics8020037 · Cited by 237
Hilty, M., Betsch, B. Y., Bögli-Stuber, K., Heiniger, N., Stadler, M., Küffer, M., Kronenberg, A., Rohrer, C., Aebi, S., Endimiani, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis581 · Cited by 226
Rottier, W. C., Ammerlaan, H. S. M., & Bonten, M. J. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks065 · Cited by 225
Defining an extended-spectrum β-lactamase
Livermore, D. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01857.x · Cited by 222
Fisher, J., Belasco, J. G., Khosla, S., & Knowles, J. R. (1980) · Biochemistry · doi:10.1021/bi00554a012 · Cited by 221
Kazmierczak, K. M., Rabine, S., Hackel, M., McLaughlin, R. E., Biedenbach, D. J., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02379-15 · Cited by 220
Self-citationRasmussen, B. A., Bush, K., Keeney, D., Yang, Y., Hare, R., O'Gara, C., & Medeiros, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2080 · Cited by 217
Self-citationClassification of beta-lactamases: groups 1, 2a, 2b, and 2b'
Bush, K. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.3.264 · Cited by 211
Self-citationExtended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01410-08 · Cited by 211
MUTATIONAL SPECIFICITY IN BACTERIA
Miller, J. H. (1983) · Annual Review of Genetics · doi:10.1146/annurev.ge.17.120183.001243 · Cited by 209
OXA-48-like carbapenemases producing Enterobacteriaceae in different niches
Mairi, A., Pantel, A., Sotto, A., Lavigne, J.-P., & Touati, A. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3112-7 · Cited by 205
Stewardson, A. J., Allignol, A., Beyersmann, J., Graves, N., Schumacher, M., Meyer, R., Tacconelli, E., De Angelis, G., Farina, C., Pezzoli, F., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.33.30319 · Cited by 204
Girlich, D., Naas, T., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2043-2048.2004 · Cited by 201
Palzkill, T. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00016 · Cited by 199
Serio, A. W., Keepers, T., Andrews, L., & Krause, K. M. (2018) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0002-2018 · Cited by 197
Haidar, G., Clancy, C. J., Shields, R. K., Hao, B., Cheng, S., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02534-16 · Cited by 193
AmpC β-lactamase-producing Enterobacterales: what a clinician should know
Meini, S., Tascini, C., Cei, M., Sozio, E., & Rossolini, G. M. (2019) · Infection · doi:10.1007/s15010-019-01291-9 · Cited by 190
Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance
Mölstad, S., Löfmark, S., Carlin, K., Erntell, M., Aspevall, O., Blad, L., Hanberger, H., Hedin, K., Hellman, J., Norman, C., et al. (2017) · Bulletin of the World Health Organization · doi:10.2471/blt.16.184374 · Cited by 188
Intrinsic resistance to β‐lactam antibiotics in staphylococcus aureus
Brown, D. F. J., & Reynolds, P. E. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80455-8 · Cited by 187
Carbapenem-Resistant Strain of Klebsiellaoxytoca Harboring Carbapenem-Hydrolyzingβ-LactamaseKPC-2
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., Bush, K., & Tenover, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3881-3889.2003 · Cited by 187
Self-citationEXTENDED-SPECTRUM β-LACTAMASES AND OTHER ENZYMES PROVIDING RESISTANCE TO OXYIMINO-β-LACTAMS
Jacoby, G. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70395-0 · Cited by 184
Hiramatsu, K., Asada, K., Suzuki, E., Okonogi, K., & Yokota, T. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80039-j · Cited by 182
Sequence of PSE-2 beta-lactamase
Huovinen, P., Huovinen, S., & Jacoby, G. A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.134 · Cited by 180
Bajpai, T., Pandey, M., Varma, M., & Bhatambare, G. S. (2017) · Avicenna Journal of Medicine · doi:10.4103/2231-0770.197508 · Cited by 180
Epidemiology of Conjugative Plasmid-Mediated AmpC β-Lactamases in the United States
Alvarez, M., Tran, J. H., Chow, N., & Jacoby, G. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.533-537.2004 · Cited by 178
Lascols, C., Peirano, G., Hackel, M., Laupland, K. B., & Pitout, J. D. D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01686-12 · Cited by 177
Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods
Poirel, L., Bonnin, R. A., & Nordmann, P. (2012) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.02.008 · Cited by 173
Navon-Venezia, S., Leavitt, A., Schwaber, M. J., Rasheed, J. K., Srinivasan, A., Patel, J. B., & Carmeli, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00987-08 · Cited by 170
Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam
Reuland, E. A., al Naiemi, N., Kaiser, A. M., Heck, M., Kluytmans, J. A. J. W., Savelkoul, P. H. M., Elders, P. J. M., & Vandenbroucke-Grauls, C. M. J. E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv441 · Cited by 170
Castanheira, M., Huband, M. D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00567-17 · Cited by 170
Nelson, K., Hemarajata, P., Sun, D., Rubio-Aparicio, D., Tsivkovski, R., Yang, S., Sebra, R., Kasarskis, A., Nguyen, H., Hanson, B. M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00989-17 · Cited by 170
Deshpande, L. M., Jones, R. N., Fritsche, T. R., & Sader, H. S. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.223 · Cited by 169
Castanheira, M., Deshpande, L. M., Mendes, R. E., Canton, R., Sader, H. S., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy347 · Cited by 169
Manual of Clinical Microbiology
Flanagan, P. (1992) · Journal of Epidemiology and Community Health · doi:10.1136/jech.46.3.318 · Cited by 166
Thompson, J. S., & Malamy, M. H. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.5.2584-2593.1990 · Cited by 164
MEDEIROS, A. A. (1984) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071942 · Cited by 164
Yang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 163
Nordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas, M. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
McDanel, J. S., Schweizer, M. L., Crabb, V., Nelson, R. E., Samore, M. H., Khader, K., Blevins, A., Diekema, D. J., Chiang, H., Nair, R., et al. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.156 · Cited by 161
Rodríguez, M. M., Power, P. P., Radice, M. A., Vay, C. A., Famiglietti, A. M. R., Galleni, M., Ayala, J. A., & Gutkind, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4895-4897.2004 · Cited by 159
Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008–2014
Peirano, G., Matsumura, Y., Adams, M. D., Bradford, P., Motyl, M., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2406.171648 · Cited by 159
Self-citationPoirel, L., Castanheira, M., Carrër, A., Rodriguez, C. P., Jones, R. N., Smayevsky, J., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00022-11 · Cited by 155
Hamzaoui, Z., Ocampo-Sosa, A. A., Martinez, M. F., Landolsi, S., Ferjani, S., Maamar, E., Saïdani, M., Slim, A. F., Martı́nez-Martı́nez, L., & Boubaker, I. B.-B. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.03.020 · Cited by 153
Karlowsky, J. A., Hackel, M., Tsuji, M., Yamano, Y., ECHOLS, R. M., & Sahm, D. F. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.007 · Cited by 149
Brockman, E. W. (1974) · Springer eBooks · doi:10.1007/978-3-642-65678-1_19 · Cited by 148
Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases ,
Ke, W., Bethel, C. R., Thomson, J. M., Bonomo, R. A., & van den Akker, F. (2007) · Biochemistry · doi:10.1021/bi700300u · Cited by 144
Haidar, G., Clancy, C. J., Chen, L., Samanta, P., Shields, R. K., Kreiswirth, B. N., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00642-17 · Cited by 142
Castanheira, M., Mills, J. C., Farrell, D. J., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03681-14 · Cited by 141
Yocum, R. R., Waxman, D. J., Rasmussen, J. R., & Strominger, J. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.6.2730 · Cited by 139
Integrons and gene cassettes: hotspots of diversity in bacterial genomes
Hall, R. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06588.x · Cited by 136
AmpC -lactamases: what do we need to know for the future?
Hanson, N. D. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg284 · Cited by 134
Bradford, P. A., Cherubin, C. E., Idemyor, V., Rasmussen, B. A., & Bush, K. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.761 · Cited by 133
Self-citationSader, H. S., Castanheira, M., Duncan, L. R., & Flamm, R. K. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.04.012 · Cited by 131
Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria
Bush, K., Freudenberger, J. S., & SYKES, R. B. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.3.414 · Cited by 128
Self-citationThe negative regulator of β-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase
Höltje, J.-V., Kopp, U., Ursinus, A., et al. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07159.x · Cited by 128
Queenan, A. M., Torres‐Viera, C., Gold, H. S., Carmeli, Y., Eliopoulos, G. M., Moellering, R. C., Quinn, J. P., Hindler, J. F., Medeiros, A. A., & Bush, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3035-3039.2000 · Cited by 128
Self-citationWalsh, T. R., MacGowan, A. P., & Bennett, P. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1460 · Cited by 121
Bradford, P. A., Urban, C. M., Jaiswal, A., Mariano, N., Rasmussen, B. A., Projan, S. J., Rahal, J. J., & Bush, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.899 · Cited by 120
Self-citationOliver, A., Pérez-Díaz, J. C., Coque, T. M., Baquero, F., & Cantón, R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.616-620.2001 · Cited by 120
Piotrowska, M. J., Przygodzińska, D., Matyjewicz, K., & Popowska, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00863 · Cited by 119
β-Lactamase Genes of the Penicillin-SusceptibleBacillus anthracisSterne Strain
Chen, Y., Succi, J., Tenover, F. C., & Koehler, T. M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.823-830.2003 · Cited by 118
A 1998 Survey of Extended-Spectrum β-Lactamases in Enterobacteriaceae in France
de Champs, C., Sirot, D., Chanal, C., Bonnet, R., Sirot, J., & the French Study Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3177-3179.2000 · Cited by 118
Drug Resistance of Enteric Bacteria
Sawai, T., Mitsuhashi, S., & Yamagishi, S. (1968) · Japanese Journal of Microbiology · doi:10.1111/j.1348-0421.1968.tb00415.x · Cited by 118
Tschudin‐Sutter, S., Lucet, J., Mutters, N. T., Tacconelli, E., Zahar, J., & Harbarth, S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix258 · Cited by 116
IRT and CMT β-lactamases and inhibitor resistance
Cantón, R., Morosini, M.-I., Martin, O., de la Maza, S., & de la Pedrosa, E. G. G. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01849.x · Cited by 115
Global Molecular Epidemiology of IMP-Producing Enterobacteriaceae
Matsumura, Y., Peirano, G., Motyl, M. R., Adams, M. D., Chen, L., Kreiswirth, B. N., DeVinney, R., & Pitout, J. D. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02729-16 · Cited by 115
Livorsi, D. J., Chorazy, M. L., Schweizer, M. L., Balkenende, E., Blevins, A., Nair, R., Samore, M. H., Nelson, R. E., Khader, K., & Perencevich, E. N. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0346-9 · Cited by 115
Marsh, J. W., Mustapha, M. M., Griffith, M. P., Evans, D. R., Ezeonwuka, C. D., Pasculle, A. W., Shutt, K. A., Sundermann, A. J., Ayres, A. M., Shields, R. K., et al. (2019) · mBio · doi:10.1128/mbio.01945-19 · Cited by 115
Kazmierczak, K. M., Biedenbach, D. J., Hackel, M., Rabine, S., DeJonge, B. L. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00107-16 · Cited by 113
Self-citationCarbapenemases: Partners in crime
Bush, K. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.01.005 · Cited by 112
Self-citationProperties of novel beta-lactamase produced by Bacteroides fragilis
Yotsuji, A., Minami, S., Inoue, M., & Mitsuhashi, S. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.6.925 · Cited by 112
Ceftazidime/avibactam resistance associated with L169P mutation in the omega loop of KPC-2
Hemarajata, P., & Humphries, R. M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz026 · Cited by 112
Zhang, Y., Kashikar, A., Brown, C. A., Denys, G. A., & Bush, K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00389-17 · Cited by 107
Self-citationMalchione, M. D., Torres, L. M., Hartley, D., Koch, M., & Goodman, J. L. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.07.019 · Cited by 106
Bocanegra‐Ibarias, P., Garza‐González, E., Morfín‐Otero, R., Barrios, H., Villarreal-Treviño, L., Rodríguez-Noriega, E., Garza–Ramos, U., Petersen-Morfín, S., & Silva-Sánchez, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179651 · Cited by 103
Characterization of four beta-lactamases produced by Staphylococcus aureus
Zygmunt, D. J., Stratton, C. W., & Kernodle, D. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.440 · Cited by 102
Carbapenem Resistance in Elizabethkingia meningoseptica Is Mediated by Metallo-β-Lactamase BlaB
González, L. J., & Vila, A. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05835-11 · Cited by 102
Armand-Lefèvre, L., Leflon‐Guibout, V., Bredin, J., Barguellil, F., Amor, A., Pagès, J., & Nicolas-Chanoine, M.-H. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1165-1168.2003 · Cited by 102
Single amino acid substitution between SHV‐1 β‐lactamase and cefotaxime‐hydrolyzing SHV‐2 enzyme
Barthélémy, M., Péduzzi, J., Yaghlane, H. B., & Labia, R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80734-8 · Cited by 99
Mojica, M. F., Rutter, J. D., Taracila, M. A., Abriata, L. A., Fouts, D. E., Papp‐Wallace, K. M., Walsh, T. J., LiPuma, J. J., Vila, A. J., & Bonomo, R. A. (2019) · mBio · doi:10.1128/mbio.00405-19 · Cited by 99
Nallapareddy, S. R., Huang, W., Weinstock, G. M., & Murray, B. E. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.16.5709-5718.2005 · Cited by 98
Pfaller, M. A., Huband, M. D., Mendes, R. E., Flamm, R. K., & Castanheira, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.02.021 · Cited by 96
Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India
Kumarasamy, K., & Kalyanasundaram, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr431 · Cited by 95
Collaborators, S., Galani, I., Nafplioti, K., Adamou, P., Karaiskos, I., Giamarellou, H., & Souli, M. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3801-1 · Cited by 95
Périchon, B., Goussard, S., Walewski, V., Křížová, L., Cerqueira, G., Murphy, C. I., Feldgarden, M., Wortman, J. R., Clermont, D., Nemec, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01261-13 · Cited by 94
First Report of the Metallo-β-Lactamase SPM-1 in Europe
Salabi, A. A. E., Toleman, M. A., Weeks, J. L., Bruderer, T., Frei, R., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-09 · Cited by 93
Genomic epidemiology of global VIM-producing Enterobacteriaceae
Matsumura, Y., Peirano, G., DeVinney, R., Bradford, P. A., Motyl, M. R., Adams, M. D., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx148 · Cited by 93
Self-citationPagani, L., Colinon, C., Migliavacca, R., Labonia, M., Docquier, J., Nucleo, E., Spalla, M., Bergoli, M. L., & Rossolini, G. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.3824-3828.2005 · Cited by 92
Molecular Characterization of Carbapenemase Production Among Gram-Negative Bacteria in Saudi Arabia
Memish, Z. A., Assiri, A. M., Almasri, M. M., Roshdy, H., Hathout, H. M., Kaase, M., Gatermann, S. G., & Yezli, S. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0121 · Cited by 91
Moland, E. S., Black, J. A., Hossain, A., Hanson, N. D., Thomson, K. S., & Pottumarthy, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2382-2383.2003 · Cited by 91
Rojas, L. J., Weinstock, G. M., Cadena, E. D. L., Díaz, L., Ríos, R., Hanson, B., Brown, J. S., Vats, P., Phillips, D. S., Nguyen, H. T., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix524 · Cited by 91
Kazmierczak, K. M., Bradford, P. A., Stone, G. G., DeJonge, B. L. M., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00592-18 · Cited by 91
Self-citationSegatore, B., Massidda, O., Satta, G., Setacci, D., & Amicosante, G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1324 · Cited by 88
Distribution and expression of beta-lactamase genes among Aeromonas spp
Walsh, T. R. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.2.171 · Cited by 87
Lutgring, J. D., Zhu, W., de Man, T. J. B., Avillan, J. J., Anderson, K. F., Lonsway, D. R., Rowe, L. A., Batra, D. G., Rasheed, J. K., & Limbago, B. M. (2018) · Emerging infectious diseases · doi:10.3201/eid2404.171377 · Cited by 86
Sader, H. S., Castanheira, M., Mendes, R. E., & Flamm, R. K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky279 · Cited by 86
Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei
Rholl, D. A., Papp‐Wallace, K. M., Tomaras, A. P., Vasil, M. L., Bonomo, R. A., & Schweizer, H. P. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00139 · Cited by 84
Snydman, D. R., Jacobus, N. V., McDermott, L. A., Goldstein, E. J. C., Harrell, L. J., Jenkins, S. G., Newton, D. W., Patel, R., & Hecht, D. W. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.11.003 · Cited by 82
Solgi, H., Badmasti, F., Aminzadeh, Z., Giske, C. G., Pourahmad, M., Vaziri, F., Havaei, S. A., & Shahcheraghi, F. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3035-3 · Cited by 82
Mojica, M. F., Papp‐Wallace, K. M., Taracila, M. A., Barnes, M. D., Rutter, J. D., Jacobs, M. R., LiPuma, J. J., Walsh, T. J., Vila, A. J., & Bonomo, R. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00777-17 · Cited by 81
NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas
Rojas, L. J., Hujer, A. M., Rudin, S. D., Wright, M. S., Domitrovic, T., Marshall, S. H., Hujer, K. M., Richter, S. S., Cober, E., Pérez, F., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00454-17 · Cited by 80
Pollett, S., Miller, S. A., Hindler, J. A., Uslan, D. Z., Carvalho, M., & Humphries, R. M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01397-14 · Cited by 79
Feng, J., Qiu, Y., Yin, Z., Chen, W., Yang, H., Yang, W., Wang, J., Gao, Y., & Zhou, D. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv232 · Cited by 79
Papp‐Wallace, K. M., Becka, S. A., Zeiser, E. T., Ohuchi, N., Mojica, M. F., Gatta, J. A., Falleni, M., Tosi, D., Borghi, E., Winkler, M., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00020 · Cited by 79
Senchyna, F., Gaur, R. L., Sandlund, J., Truong, C., Tremintin, G., Kültz, D., Gómez, C. A., Tamburini, F. B., Andermann, T. M., Bhatt, A. S., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.004 · Cited by 78
Solgi, H., Badmasti, F., Giske, C. G., Aghamohammad, S., & Shahcheraghi, F. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky081 · Cited by 72
Kaye, K. S., Gold, H. S., Schwaber, M. J., Venkataraman, L., Qi, Y., Girolami, P. C. D., Samore, M. H., Anderson, G., Rasheed, J. K., & Tenover, F. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1520-1525.2004 · Cited by 71
Bosch, T., Lutgens, S. P. M., Hermans, M. H. A., Wever, P. C., Schneeberger, P. M., Renders, N. H. M., Leenders, A. C. A. P., Kluytmans, J. A. J. W., Schoffelen, A. F., Notermans, D. W., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00535-17 · Cited by 71
Research works printed but not linked: 132
- WHO. 2019. No time to wait: securing the future from drug-resistant infections. Report to the Secretary-General of the United Nations. World Health Organization, Geneva, Switzerland.
- 10.1016/S1473-3099(19)30210-5 · doi:10.1016/s1473-3099(19)30210-5
- 10.3109/00365548.2012.669046 · DOI
- 10.1007/978-3-319-78538-7 · doi:10.1007/978-3-319-78538-7
- 10.1111/j.1432-1033.1977.tb11924.x · doi:10.1111/j.1432-1033.1977.tb11924.x
- 10.2174/0929866524666170724160623 · doi:10.2174/0929866524666170724160623
- 10.1128/AAC.00960-06 · doi:10.1128/aac.00960-06
- 10.1016/j.ijantimicag.2019.01.009 · doi:10.1016/j.ijantimicag.2019.01.009
- 10.1093/jac/dku568 · DOI
- 10.1128/AAC.01413-16 · DOI
- 10.1093/jac/dkx158 · doi:10.1093/jac/dkx158
- 10.1016/j.jgar.2018.08.021 · doi:10.1016/j.jgar.2018.08.021
- 10.1128/AAC.01970-17 · doi:10.1128/aac.01970-17
- 10.1016/j.ijid.2016.11.010 · doi:10.1016/j.ijid.2016.11.010
- 10.3389/fmicb.2019.00404 · doi:10.3389/fmicb.2019.00404
- 10.1017/S0950268806007023 · doi:10.1017/s0950268806007023
- 10.1007/s10096-012-1623-9 · doi:10.1007/s10096-012-1623-9
- 10.1128/AAC.00415-12 · doi:10.1128/aac.00415-12
- 10.1099/mic.0.000183 · doi:10.1099/mic.0.000183
- 10.1007/pl00015019 · doi:10.1007/pl00015019
- 10.1086/646136 · doi:10.1086/646136
- 10.1136/bmj.2.4627.565 · doi:10.1136/bmj.2.4627.565
- 10.3389/fmicb.2017.01359 · DOI
- 10.1128/AAC.02621-12 · doi:10.1128/aac.02621-12
- 10.1128/jb.178.24.7248-7253.1996 · doi:10.1128/jb.178.24.7248-7253.1996
- 10.1021/bi9908787 · doi:10.1021/bi9908787
- 10.1128/aac.33.11.1946 · doi:10.1128/aac.33.11.1946
- 10.1128/AAC.40.8.1926 · doi:10.1128/aac.40.8.1926
- 10.1016/j.jmii.2012.08.008 · doi:10.1016/j.jmii.2012.08.008
- 10.1128/aac.44.2.428-432.2000 · doi:10.1128/aac.44.2.428-432.2000
- 10.1093/jac/dkt233 · doi:10.1093/jac/dkt233
- 10.1128/AAC.00050-10 · doi:10.1128/aac.00050-10
- 10.1128/AAC.00856-09 · doi:10.1128/aac.00856-09
- 10.1186/s13756-018-0436-8 · doi:10.1186/s13756-018-0436-8
- 10.1016/0167-4781(94)90011-6 · doi:10.1016/0167-4781(94)90011-6
- 10.1093/jac/49.2.387 · doi:10.1093/jac/49.2.387
- 10.1128/AAC.00682-07 · doi:10.1128/aac.00682-07
- 10.1128/aac.46.10.3215-3222.2002 · doi:10.1128/aac.46.10.3215-3222.2002
- 10.1016/0732-8893(94)90004-3 · doi:10.1016/0732-8893(94)90004-3
- 10.1128/AAC.02252-12 · doi:10.1128/aac.02252-12
- 10.1016/j.burns.2012.01.005 · doi:10.1016/j.burns.2012.01.005
- 10.1371/journal.pone.0180121 · doi:10.1371/journal.pone.0180121
- 10.1099/jmm.0.016337-0 · doi:10.1099/jmm.0.016337-0
- 10.1128/AAC.00634-11 · doi:10.1128/aac.00634-11
- 10.1016/j.nmni.2017.10.005 · DOI
- 10.1128/AAC.00363-06 · doi:10.1128/aac.00363-06
- 10.1016/j.diagmicrobio.2017.01.008 · doi:10.1016/j.diagmicrobio.2017.01.008
- 10.1093/jac/dkw567 · doi:10.1093/jac/dkw567
- 10.1093/jac/dku040 · doi:10.1093/jac/dku040
- 10.1093/jac/dky028 · doi:10.1093/jac/dky028
- 10.1186/s12941-015-0112-2 · doi:10.1186/s12941-015-0112-2
- 10.1016/j.ijantimicag.2018.05.015 · doi:10.1016/j.ijantimicag.2018.05.015
- 10.1128/AAC.01904-17 · doi:10.1128/aac.01904-17
- 10.1128/mBio.00528-17 · doi:10.1128/mbio.00528-17
- 10.1128/AAC.02610-16 · doi:10.1128/aac.02610-16
- 10.1016/j.jgar.2019.07.027 · doi:10.1016/j.jgar.2019.07.027
- 10.1128/genomeA.00659-15 · doi:10.1128/genomea.00659-15
- 10.1128/AAC.01823-16 · doi:10.1128/aac.01823-16
- 10.1099/jmm.0.000771 · doi:10.1099/jmm.0.000771
- 10.1016/j.jgar.2019.05.014 · doi:10.1016/j.jgar.2019.05.014
- 10.1128/AAC.00160-18 · doi:10.1128/aac.00160-18
- 10.1016/j.diagmicrobio.2016.12.012 · doi:10.1016/j.diagmicrobio.2016.12.012
- 10.1093/jac/dkw242 · doi:10.1093/jac/dkw242
- 10.1128/JB.00375-06 · doi:10.1128/jb.00375-06
- 10.1017/S0950268818000249 · doi:10.1017/s0950268818000249
- 10.1093/jac/dkx325 · doi:10.1093/jac/dkx325
- 10.1128/AAC.00191-19 · doi:10.1128/aac.00191-19
- 10.1016/j.diagmicrobio.2016.02.005 · doi:10.1016/j.diagmicrobio.2016.02.005
- 10.1099/jmm.0.038323-0 · doi:10.1099/jmm.0.038323-0
- 10.1128/AEM.01360-19 · doi:10.1128/aem.01360-19
- 10.1016/j.jgar.2017.06.001 · doi:10.1016/j.jgar.2017.06.001
- 10.1128/aac.30.5.645 · doi:10.1128/aac.30.5.645
- 10.1128/aac.34.8.1590 · doi:10.1128/aac.34.8.1590
- 10.1111/j.1365-2958.1994.tb00999.x · doi:10.1111/j.1365-2958.1994.tb00999.x
- 10.1016/j.anaerobe.2019.01.011 · DOI
- 10.1016/j.anaerobe.2017.10.003 · doi:10.1016/j.anaerobe.2017.10.003
- 10.1017/ice.2019.110 · doi:10.1017/ice.2019.110
- 10.1128/jb.170.6.2873-2878.1988 · doi:10.1128/jb.170.6.2873-2878.1988
- 10.1128/aac.47.6.2040-2042.2003 · doi:10.1128/aac.47.6.2040-2042.2003
- 10.1128/JB.00691-09 · doi:10.1128/jb.00691-09
- 10.1016/j.jhin.2014.01.009 · doi:10.1016/j.jhin.2014.01.009
- 10.1089/mdr.2017.0206 · doi:10.1089/mdr.2017.0206
- 10.1093/jac/dky303 · doi:10.1093/jac/dky303
- 10.1128/JCM.02316-16 · doi:10.1128/jcm.02316-16
- 10.1128/AAC.00707-08 · doi:10.1128/aac.00707-08
- 10.2147/IDR.S174869 · DOI
- 10.1128/JCM.00258-06 · doi:10.1128/jcm.00258-06
- 10.1093/jac/dkg239 · doi:10.1093/jac/dkg239
- 10.1128/JCM.01573-07 · doi:10.1128/jcm.01573-07
- 10.1093/jac/dkm471 · doi:10.1093/jac/dkm471
- 10.2807/ese.14.21.19218-en · doi:10.2807/ese.14.21.19218-en
- 10.1099/jmm.0.000217 · doi:10.1099/jmm.0.000217
- 10.1016/j.jgar.2019.06.008 · doi:10.1016/j.jgar.2019.06.008
- 10.1093/jac/dkq408 · DOI
- 10.1128/AAC.00562-17 · doi:10.1128/aac.00562-17
- 10.1093/jac/dkz176 · DOI
- 10.1016/j.ijantimicag.2008.11.014 · doi:10.1016/j.ijantimicag.2008.11.014
- 10.1128/aac.32.11.1660 · doi:10.1128/aac.32.11.1660
- 10.1093/jac/dky284 · doi:10.1093/jac/dky284
- 10.1128/AAC.02529-18 · DOI
- 10.15585/mmwr.mm6830a4 · doi:10.15585/mmwr.mm6830a4
- 10.1128/aac.44.8.2230-2230.2000 · doi:10.1128/aac.44.8.2230-2230.2000
- Fisher JF, Knowles JR. 1978. Bacterial resistance to β-lactams: the β-lactamases. Ann Rep Med Chem 13:239–248.
- 10.1128/aac.38.2.392 · doi:10.1128/aac.38.2.392
- 10.1128/AAC.00043-13 · doi:10.1128/aac.00043-13
- 10.1097/INF.0b013e31824d1a11 · doi:10.1097/inf.0b013e31824d1a11
- 10.1016/j.burns.2014.02.008 · doi:10.1016/j.burns.2014.02.008
- 10.1016/j.jhin.2014.05.007 · doi:10.1016/j.jhin.2014.05.007
- Al-Charrakh AH, Al-Awadi SJ, Mohammed AS. 2016. Detection of metallo-beta-lactamase producing Pseudomonas aeruginosa isolated from public and private hospitals in Baghdad, Iraq. Acta Med Iran 54:107–113.
- 10.15585/mmwr.mm6721a6 · doi:10.15585/mmwr.mm6721a6
- 10.1016/j.jhin.2015.10.001 · doi:10.1016/j.jhin.2015.10.001
- 10.1016/j.cmi.2016.10.005 · doi:10.1016/j.cmi.2016.10.005
- 10.1093/cid/cix615 · doi:10.1093/cid/cix615
- 10.1128/AAC.00948-19 · doi:10.1128/aac.00948-19
- 10.1016/j.ijantimicag.2012.02.009 · doi:10.1016/j.ijantimicag.2012.02.009
- 10.1128/JCM.00727-15 · doi:10.1128/jcm.00727-15
- 10.1093/jac/dkq190 · doi:10.1093/jac/dkq190
- Fortney T, Zhang Y, Campbell A, Carpenter J, Sultana R, Bush K. 2018. Microbiological response of Serratia marcescens isolates to β-lactamase inhibitor combinations in the presence of KPC and SME carbapenemases, Sunday-484. Abstr ASM Microbe 2018. American Society for Microbiology, Washington, DC.
- 10.1128/AAC.02282-18 · doi:10.1128/aac.02282-18
- 10.1186/s13756-017-0182-3 · doi:10.1186/s13756-017-0182-3
- 10.2807/1560-7917.ES.2017.22.6.30461 · doi:10.2807/1560-7917.es.2017.22.6.30461
- 10.7860/JCDR/2014/7952.4413 · DOI
- 10.1128/AAC.00789-13 · doi:10.1128/aac.00789-13
- 10.1128/AAC.00536-13 · doi:10.1128/aac.00536-13
- 10.1080/1120009X.2017.1323149 · doi:10.1080/1120009x.2017.1323149
- 10.1186/s12879-018-3114-9 · DOI
- 10.1089/mdr.2017.0165 · doi:10.1089/mdr.2017.0165
- 10.2807/1560-7917.ES.2017.22.19.30530 · doi:10.2807/1560-7917.es.2017.22.19.30530
- 10.1038/emi.2016.24 · doi:10.1038/emi.2016.24
- 10.1016/j.ijantimicag.2015.07.008 · doi:10.1016/j.ijantimicag.2015.07.008
- 10.1016/j.ijantimicag.2014.12.013 · doi:10.1016/j.ijantimicag.2014.12.013
- 10.1016/j.ijantimicag.2012.08.015 · doi:10.1016/j.ijantimicag.2012.08.015
Cited by
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Castanheira, M., Simner, P. J., & Bradford, P. A. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab092 · Cited by 796
Self-citationTamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac268 · Cited by 526
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1478 · Cited by 441
Metadata
- Authors
- Bush, K., & Bradford, P. A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-03-18
- Volume
- 33
- Issue
- 2
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3007020664
- Cited by
- 938
- References
- 270
- FWCI
- 29.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.